Heparin challenge test in patients undergoing cardiac surgery: dealing with heparin allergy.


Journal

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
ISSN: 1473-5733
Titre abrégé: Blood Coagul Fibrinolysis
Pays: England
ID NLM: 9102551

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 1 2 2020
medline: 21 7 2020
entrez: 1 2 2020
Statut: ppublish

Résumé

: A history of heparin hypersensitivity in patients undergoing cardiopulmonary bypass surgery poses the dilemma of which anticoagulant to use. Here, we report the successful use of a heparin challenge test in a 66-year-old female candidate for coronary artery bypass graft surgery with a past medical history of enoxaparin type I hypersensitivity after pulmonary embolism. Challenge and desensitization protocols are effectively used for essential antibiotics in patients with severe infections and/or allergies, or patients with aspirin intolerance requiring revascularization for coronary disease. A successful use of desensitization protocols to unfractionated heparin has been previously described in four patients undergoing cardiac surgery with various schemes. However, our case report indicates that a challenge test may also offer a quick, safe and effective approach in patients with a history of hypersensitivity reactions to heparin with inconclusive diagnostic tests and/or whenever the use of alternative heparins is tricky.

Identifiants

pubmed: 32004200
doi: 10.1097/MBC.0000000000000883
pii: 00001721-202003000-00009
doi:

Substances chimiques

Enoxaparin 0
Heparin 9005-49-6

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-169

Références

Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg 2013; 116:1210–1222.
Rehfeldt KH, Barbara DW. Cardiopulmonary bypass without heparin. Semin Cardiothorac Vasc Anesth 2016; 20:40–51.
Trautmann A, Seitz CS. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection. Immunol Allergy Clin North Am 2009; 29:469–480.
Schindewolf M, Lindhoff-Last E, Ludwig RJ, Boehncke WH. Heparin-induced skin lesions. Lancet 2012; 380:1867–1879.
Gonzalez-Delgado P, Fernandez J. Hypersensitivity reactions to heparins. Curr Opin Allergy Clin Immunol 2016; 16:315–322.
Scherer K, Tsakiris DA, Bircher AJ. Hypersensitivity reaction to anticoagulant drugs. Curr Pharm Des 2008; 14:2863–2873.
Gatt P, Galea SA, Busuttil W, Grima C, Muscat J, Farrugia Y. Bivalirudin as an alternative anticoagulation for cardiopulmonary bypass during adult cardiac surgery – a change in practice. J Extra Corpor Technol 2017; 49:49–53.
Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, et al. General considerations on rapid desensitization for drug hypersensitivity – a consensus statement. Allergy 2010; 65:1357–1366.
Turvey SE, Cronin B, Arnold AD, Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 2004; 92:426–432.
Borish L, Tamir R, Rosenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987; 80:314–319.
Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol 1982; 69:275–282.
Castells M, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122:574–580.
Wendel GD Jr, Stark BJ, Jamison RB, Molina RD, Sullivan TJ. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312:1229–1232.
Dave S, Park MA. Successful heparin desensitization: a case report and review of the literature. J Card Surg 2008; 23:394–397.
Parekh K, Burkhart HM, Hatab A, Ross A, Muller BA. Heparin allergy: successful desensitization for cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130:1455–1456.
Patriarca G, Rossi M, Schiavino D, Schinco G, Fais G, Varano C, et al. Rush desensitization in heparin hypersensitivity: a case report. Allergy 1994; 49:292–294.
Eryani AY, al-Momen AK, Fayed DF, Allam AK. Successful heparin desensitization after heparin-induced anaphylactic shock. Thromb Res 1995; 79:523–526.

Auteurs

Mauro Cancian (M)

Department of Medicine.

Elisabetta Borella (E)

Department of Medicine.

Augusto D'Onofrio (A)

Department of Cardiac, Thoracic and Vascular Sciences, Padova University Hospital, Padova, Italy.

Gino Gerosa (G)

Department of Cardiac, Thoracic and Vascular Sciences, Padova University Hospital, Padova, Italy.

Paolo Simioni (P)

Department of Medicine.

Elena Campello (E)

Department of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH